Strata Oncology
PrivateLast Round
Series C
Extension
Nov 22, 2024
Total Funding Raised
$139.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Strata Oncology is a healthcare and biotechnology company that accelerates the impact of precision medicine for cancer patients by partnering with major healthcare systems to provide rapid genomic sequencing of tumor biopsies, enabling tailored therapies and drug trials.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Strata Oncology Comparables
Compare Strata Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roche Holding | 84% | |
| Inocras | 81% | |
| Guardant Health | 80% |
Strata Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Nov 22, 2024 | ||||
| Series C | Jul 28, 2021 | ||||
| Series B Extension | Nov 4, 2020 | ||||
| Series B | May 23, 2018 | ||||
| Series A | Jun 1, 2016 |
Key People
Founding team and executive leadership
Strata Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series C, Series B |
| Arboretum Ventures | Series C, Series B, Series A |
| Cormorant Asset Management | Series C |
| Highside Capital Management | Series C |
| Baird Capital | Series C, Series B, Series A |
| HIGHSIDE Global | Series C |
| Pfizer Ventures | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 54% MoM, reaching 2.3K.
- Jul 24, 2026
Monthly visitors increased 52% MoM.
Strata Oncology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Strata Oncology's valuation, stock price, and market status.
Is Strata Oncology a public or private company?
Strata Oncology is a private company.
What is the current stock price of Strata Oncology?
Strata Oncology is a private company with no public stock price. No recent secondary market data is available.
How much is Strata Oncology worth (valuation)?
Valuation information for Strata Oncology is not publicly available.
Can I buy Strata Oncology stock?
Strata Oncology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Strata Oncology's last funding round?
Strata Oncology's most recent funding round was Series C Extension on November 22, 2024.
Who are the main investors in Strata Oncology?
Key investors in Strata Oncology include Arboretum Ventures, Baird Capital, Pfizer Ventures, Wellington Management.
Will Strata Oncology IPO soon?
No public IPO plans have been announced for Strata Oncology.
How can I track Strata Oncology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Strata Oncology's secondary market activity and sign up for updates.